Clinical Trials Browser

Advanced BRAF Mutant Cancers × binimetinib × Clear all

NCT03843775 2024-10-21

A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers

Phase 1/2 Completed

17 enrolled 9 charts

Advanced BRAF Mutant Cancers